Search
Search Results
##search.searchResults.foundPlural##
-
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3034PDF: 1110HTML: 369 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1869PDF: 770HTML: 204 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2545PDF: 1047HTML: 99 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
988PDF: 931HTML: 302 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1926PDF: 1355HTML: 246 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4337PDF: 1871HTML: 17709 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1694PDF: 933HTML: 126 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1729PDF: 780HTML: 10206Figures 1,2,3: 152 -
-
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2326PDF: 825HTML: 2440 -
-
-
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
740PDF: 476HTML: 92 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1143PDF: 688HTML: 1203 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2075PDF: 842HTML: 300 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3669PDF: 1415HTML: 459Figures . Eliassian: 203 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2510PDF: 837HTML: 17443Fig1 Caligaris: 145Fig.2 Caliga: 176 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3055PDF: 1565HTML: 392 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3999PDF: 1534HTML: 836 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
901PDF: 448HTML: 63 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3561PDF: 1369HTML: 168 -
CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates
1885PDF: 1095HTML: 233 -
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3183PDF: 1909HTML: 7452 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1310PDF: 854HTML: 1758 -
DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS
1951PDF: 1178HTML: 1910Untitled: 133TaBles Neinates sepsis: 156 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
624PDF: 482HTML: 199 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1447PDF: 1132HTML: 171 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
928PDF: 511HTML: 7798 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4130PDF: 1486HTML: 426 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1176PDF: 555HTML: 2839ATRA induced Reactive Hemophagocytosis: A Case Report: 178







